The introduction of inclisiran

In January 2020, the UK Government's Department of Health and Social Care (DHSC) announced ‘a ground-breaking, in-principle agreement with Novartis’, namely, the introduction of inclisiran, (DHSC,...

Communication barriers that affect medication adherence in patients with learning disabilities

Nurse prescribing in end-of-life care in the community: meeting patients' needs

A significant amount of palliative care medicines management in the home is carried out by patients and their families or other informal carers, in the absence of direct contact and guidance by health...

Shaping and delivering services in primary care: benzodiazepine and opiate withdrawal service

Good practice in prescribing opioid medicines for pain should reflect fundamental principles in prescribing generally. The decision to prescribe is underpinned by applying best professional...

Healthcare workers must be protected

For many of you in clinical practice, although you have not stopped face-to-face contact, it has not been the same as it has been previously, and many patients have found the pandemic system confusing...

Drug Updates: October

Ronapreve, a combination of two monoclonal antibodies, is the first targeted medicine developed for COVID-19 to receive marketing authorisation from the Medicines and Healthcare products Regulatory...

Drug breakdown: Alendronic acid

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate.

Novel use of psychedelics for heart disease and mental health: treatment and ethics

‘Classic psychedelics’ mainly refer to psychoactive substances known to act as agonists primarily at serotonin 2A receptors, which are often categorised into three classes: tryptamines, lysergamides,...

Analgesia prescribing in primary care

This interrupted time series analysis published in the British Journal of General Practice looks at the impact of published guidance on prescribing rates of simple analgesia in primary care settings...

Prescribing considerations in the use of oral medication in Parkinson's disease

People with Parkinson's (PwP) have depleted levels of dopamine in the brain. From the 1970s, levodopa, which is metabolised to dopamine, was utilised to treat the disabling motor symptoms. Initially...

Understanding the pharmacology of heart failure

HF is defined by the American College of Cardiology/American Heart Association (ACC/AHA) as a complex clinical syndrome that occurs from any structural or functional impairment of ventricular filling...

Changing the way type 2 diabetes is managed

The main complications of diabetes are microvascular disease affecting the eyes, nerves and kidneys, and macrovascular disease leading to cardiovascular disease (CVD), cerebrovascular disease and...